Content
02/08/2024
South San Francisco, CA USA
Neurona Therapeutics
completed $120 million Venture Round funding. Investors include
Viking Global Investors (lead), Ysios Capital, UCB Ventures, The Column Group, Spur Capital Partners, Schroders Capital, LYFE Capital, Euclidean Capital, Cormorant Asset Management, Berkeley Frontier Fund, Alexandria Venture Investments.
About
Neurona is a biotherapeutics company developing neural cell therapies with single-dose curative potential for the treatment of chronic neurological disorders. Based on a novel neural cell lineage pioneered by the company’s scientific founders, Neurona has built a robust regenerative platform and is developing neuronal, glial, and gene-edited cell therapy candidates that provide long-term repair of dysfunctional neural networks for multiple neurological disorders. For more information about Neurona visit our website.
Startup
Neurona Therapeutics
https://www.neuronatherapeutics.com
Claim Profile
Location:
South San Francisco, CA USA
Sector:
Biotech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
